Want to see HK:8156 full AI Analyst Report?
Sinopharm Tech Holdings Limited (8156) AI Stock Analysis
Sinopharm Tech Holdings Limited
(HKEX:8156)
The score is primarily constrained by highly distressed financial performance, including negative equity, recurring losses, and weak cash generation. Mixed technical indicators provide some support, but the negative P/E and absence of dividend income further limit the investment profile.
Sinopharm Tech Holdings Limited (8156) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 114.06M
- Dividend Yield
- ―
- Average Volume (3M)
- 53.52K
- Price to Earnings (P/E)
- -7.4
- Beta (1Y)
- 0.32
- Revenue Growth
- -25.58%
- EPS Growth
- -12.50%
- Country
- Hong Kong
- Employees
- 31
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Application
Sinopharm Tech Holdings Limited Business Overview & Revenue Model
Company Description
Sinopharm Tech Holdings Limited functions as an investment holding enterprise, with its primary focus on lottery operations across mainland China and Hong Kong. The company diversifies its activities into several key areas: it supplies both hardware...
Sinopharm Tech Holdings Limited Financial Statement Overview
Summary
Financial performance is very weak: the company has volatile, predominantly loss-making operations, persistently negative shareholders’ equity, and generally negative operating and free cash flow. Reduced debt and improving cash burn provide limited support, but the financial profile remains high risk.
Income Statement
27NegativeBalance Sheet
18Very NegativeCash Flow
34Negative| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 78.53M | 45.58M | 61.25M | 41.28M | 42.84M | 40.98M |
| Gross Profit | 13.60M | 6.42M | 13.52M | 5.02M | 5.47M | 5.10M |
| EBITDA | 2.75M | -6.94M | 6.11M | 4.98M | -1.01M | -75.17M |
| Net Income | -1.77M | -9.14M | -867.00K | -19.70M | -10.63M | -88.00M |
Balance Sheet | ||||||
| Total Assets | 22.44M | 22.44M | 51.74M | 44.49M | 33.48M | 76.89M |
| Cash, Cash Equivalents and Short-Term Investments | 5.62M | 5.62M | 6.95M | 2.64M | 1.78M | 2.99M |
| Total Debt | 30.73M | 30.73M | 46.73M | 73.26M | 53.00M | 45.93M |
| Total Liabilities | 71.32M | 71.32M | 88.43M | 250.09M | 213.24M | 250.28M |
| Stockholders Equity | -46.40M | -46.40M | -36.87M | -199.48M | -172.73M | -166.78M |
Cash Flow | ||||||
| Free Cash Flow | -3.48M | -4.02M | -7.21M | -12.58M | 4.73M | -36.88M |
| Operating Cash Flow | -5.93M | -4.02M | -7.21M | -9.25M | 4.73M | -36.76M |
| Investing Cash Flow | -8,000 | 2,000 | -9,000 | -4.86M | 2,000 | -85.00K |
| Financing Cash Flow | 12.01M | 3.07M | 11.50M | 14.98M | -4.52M | 32.24M |
Sinopharm Tech Holdings Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8156, the sentiment is Negative. The current price of 0.19 is above the 20-day moving average (MA) of 0.19, above the 50-day MA of 0.19, and below the 200-day MA of 0.23, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 48.92 is Neutral, neither overbought nor oversold. The STOCH value of 49.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8156.
Sinopharm Tech Holdings Limited Peers Comparison
Overall Rating
HK:988569Neutral
HK:257167.9Neutral
HK:257654Neutral
HK:814850Neutral- HK:815643Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:9885 | 69Neutral | HKD 2.35B | 10.79 | 7.63% | 3.63% | 16.99% | 126.15% |
| HK:2571 | 68Neutral | HKD 2.17B | 344.01 | 0.76% | ― | -2.29% | -91.48% |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| HK:2576 | 54Neutral | HKD 2.33B | -30.33 | -5.91% | ― | ― | ― |
| HK:8148 | 50Neutral | HKD 1.49B | 82.44 | 21.60% | ― | 151.97% | ― |
| HK:8156 | 43Neutral | HKD 122.94M | -7.38 | 20.88% | ― | -25.58% | -12.50% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:8156 | Sinopharm Tech Holdings Limited | 0.19 | -0.09 | -30.71% | |
| HK:8148 | Aurum Pacific (China) Group Ltd. | 3.25 | 1.53 | 88.95% | |
| HK:9885 | YSB Inc. | 3.44 | -5.62 | -62.01% | |
| HK:2576 | Zhejiang Taimei Medical Technology Co Ltd Class H | 4.14 | -0.10 | -2.36% | |
| HK:2571 | Beijing Saimo Technology Co. Ltd. Class H | 16.25 | 3.23 | 24.81% | |
| HK:6687 | JST Group Corporation Limited | 9.85 | -23.99 | -70.89% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 16, 2026